164 related articles for article (PubMed ID: 23037979)
61. Photodynamic effects of hypocrellin A on three human malignant cell lines by inducing apoptotic cell death.
Zhang J; Cao EH; Li JF; Zhang TC; Ma WJ
J Photochem Photobiol B; 1998 May; 43(2):106-11. PubMed ID: 9679312
[TBL] [Abstract][Full Text] [Related]
62. Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.
Kinzler I; Haseroth E; Hauser C; Rück A
Photochem Photobiol Sci; 2007 Dec; 6(12):1332-40. PubMed ID: 18046490
[TBL] [Abstract][Full Text] [Related]
63. Interaction of antiviral and antitumor photoactive drug hypocrellin A with human serum albumin.
Kocisová E; Jancura D; Sánchez-Cortés S; Miskovský P; Chinsky L; García-Ramos JV
J Biomol Struct Dyn; 1999 Aug; 17(1):111-20. PubMed ID: 10496426
[TBL] [Abstract][Full Text] [Related]
64. A study on the photodynamic properties of chlorophyll derivatives using human hepatocellular carcinoma cells.
Li WT; Tsao HW; Chen YY; Cheng SW; Hsu YC
Photochem Photobiol Sci; 2007 Dec; 6(12):1341-8. PubMed ID: 18046491
[TBL] [Abstract][Full Text] [Related]
65. Photodynamic therapy-induced apoptosis of HeLa cells.
Panzarini E; Tenuzzo B; Dini L
Ann N Y Acad Sci; 2009 Aug; 1171():617-26. PubMed ID: 19723112
[TBL] [Abstract][Full Text] [Related]
66. Chelation of hypocrellin B with zinc ions with electron paramagnetic resonance (EPR) evidence of the photodynamic activity of the resulting chelate.
Tian C; Xu S; Chen S; Shen J; Zhang M; Shen T
Free Radic Res; 2001 Nov; 35(5):543-54. PubMed ID: 11767412
[TBL] [Abstract][Full Text] [Related]
67. Photosensitization with anticancer agents. 18. Perylenequinonoid pigments as potential photodynamic therapeutic agents: preparation and photodynamic properties of amino-substituted hypocrellin derivatives.
Diwu Z; Zhang C; Lown JW
Anticancer Drug Des; 1993 Apr; 8(2):129-43. PubMed ID: 8494603
[TBL] [Abstract][Full Text] [Related]
68. Photosensitization mechanism of active species by the complex of hypocrellin B with aluminum ion.
Ma JH; Zhao JQ; Jiang LJ
Free Radic Res; 2001 Nov; 35(5):607-17. PubMed ID: 11767418
[TBL] [Abstract][Full Text] [Related]
69. Toxicity and phototoxicity of Hypocrellin A on malignant human cell lines, evidence of a synergistic action of photodynamic therapy with Imatinib mesylate.
Chio-Srichan S; Oudrhiri N; Bennaceur-Griscelli A; Turhan AG; Dumas P; Refregiers M
J Photochem Photobiol B; 2010 May; 99(2):100-4. PubMed ID: 20347325
[TBL] [Abstract][Full Text] [Related]
70. Hypocrellin-B acetate as a fluorogenic substrate for enzyme-assisted cell photosensitization.
Croce AC; Fasani E; Bottone MG; De Simone U; Santin G; Pellicciari C; Bottiroli G
Photochem Photobiol Sci; 2011 Nov; 10(11):1783-90. PubMed ID: 21894341
[TBL] [Abstract][Full Text] [Related]
71. Hypocrellin Derivative-Loaded Calcium Phosphate Nanorods as NIR Light-Triggered Phototheranostic Agents with Enhanced Tumor Accumulation for Cancer Therapy.
Wang H; Jia Q; Liu W; Nan F; Zheng X; Ding Y; Ren H; Wu J; Ge J
ChemMedChem; 2020 Jan; 15(2):177-181. PubMed ID: 31755659
[TBL] [Abstract][Full Text] [Related]
72. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids.
Marchal S; Fadloun A; Maugain E; D'Hallewin MA; Guillemin F; Bezdetnaya L
Biochem Pharmacol; 2005 Apr; 69(8):1167-76. PubMed ID: 15794937
[TBL] [Abstract][Full Text] [Related]
73. Sonodynamic and photodynamic mechanisms of action of the novel hypocrellin sonosensitizer, SL017: mitochondrial cell death is attenuated by 11, 12-epoxyeicosatrienoic acid.
El-Sikhry HE; Miller GG; Madiyalakan MR; Seubert JM
Invest New Drugs; 2011 Dec; 29(6):1328-36. PubMed ID: 20676746
[TBL] [Abstract][Full Text] [Related]
74. Wild-type p53 protein potentiates phototoxicity of 2-BA-2-DMHA in HT29 cells expressing endogenous mutant p53.
Zhang WG; Li XW; Ma LP; Wang SW; Yang HY; Zhang ZY
Cancer Lett; 1999 Apr; 138(1-2):189-95. PubMed ID: 10378792
[TBL] [Abstract][Full Text] [Related]
75. Hypocrellin B in hepatocellular carcinoma cells: Subcellular localization and sonodynamic damage.
Wang X; Luo J; Leung AW; Li Y; Zhang H; Xu C
Int J Radiat Biol; 2015 May; 91(5):399-406. PubMed ID: 25565557
[TBL] [Abstract][Full Text] [Related]
76. Oxovanadium(IV) based hypocrellin B complexes with enhanced photodynamic activity.
Sun Y; Zheng Y; Lei WH; Zhou QX; Hou YJ; Zhang BW; Wang XS
Dalton Trans; 2012 Jan; 41(2):651-7. PubMed ID: 22068883
[TBL] [Abstract][Full Text] [Related]
77. Perylenequinones in photodynamic therapy: cellular versus vascular response.
Olivo M; Chin W
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):223-37. PubMed ID: 16566720
[TBL] [Abstract][Full Text] [Related]
78. Hypocrellin derivative with improvements of red absorption and active oxygen species generation.
Xu S; Chen S; Zhang M; Shen T
Bioorg Med Chem Lett; 2004 Mar; 14(6):1499-501. PubMed ID: 15006390
[TBL] [Abstract][Full Text] [Related]
79. UVA-induced effects of 2,6-disubstituted 4-anilinoquinazolines on cancer cell lines.
Jantová S; Melušová M; Pánik M; Brezová V; Barbieriková Z
J Photochem Photobiol B; 2016 Jan; 154():77-88. PubMed ID: 26700424
[TBL] [Abstract][Full Text] [Related]
80. Electric magnetic resonance and spectrophotometry evidence on the photodynamic activity of a new perylenequinonoid pigment.
He YY; An JY; Jiang LJ
J Photochem Photobiol B; 1999 Jun; 50(2-3):166-73. PubMed ID: 10577050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
